Skip to main content

Advertisement

SpringerLink
Log in

Alzheimer disease

Navigating complexities of racial disparities in Alzheimer disease biomarkers

  • News & Views
  • Published:

From Nature Reviews Neurology

View current issue Sign up to alerts

An analysis based on datasets from four studies of memory and ageing reveals differences in the relationship of cognition with cerebrospinal fluid, but not imaging, biomarkers for Alzheimer disease between self-identified Black and White participants. These findings highlight the importance of precision medicine to address Alzheimer disease disparities across diverse populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. 2023 Alzheimer’s disease facts and figures. Alzheimers Dement. 19, 1598–1695 (2023).

  2. Iwatsubo, T., Irizarry, M. C., Lewcock, J. W. & Carrillo, M. C. Alzheimer’s targeted treatments: focus on amyloid and inflammation. J. Neurosci. 43, 7894–7898 (2023).

    Article  CAS  PubMed  Google Scholar 

  3. Jack, C. R. Jr et al. NIA-AA Research Framework: toward a biological definition of Alzheimer’s disease. Alzheimers Dement. 14, 535–562 (2018).

    Article  PubMed  Google Scholar 

  4. Hansson, O. et al. The Alzheimer’s Association appropriate use recommendations for blood biomarkers in Alzheimer’s disease. Alzheimers Dement. 18, 2669–2686 (2022).

    Article  CAS  PubMed  Google Scholar 

  5. Bonomi, S. et al. Relationships of cognitive measures with cerebrospinal fluid but not imaging biomarkers of Alzheimer disease vary between Black and White individuals. Ann. Neurol. https://doi.org/10.1002/ana.26838 (2023).

    Article  PubMed  Google Scholar 

  6. Morris, J. C. et al. Assessment of racial disparities in biomarkers for Alzheimer disease. JAMA Neurol. 76, 264–273 (2019).

    Article  PubMed  PubMed Central  Google Scholar 

  7. Deters, K. D. et al. Amyloid PET imaging in self-identified non-Hispanic Black participants of the Anti-Amyloid in Asymptomatic Alzheimer’s Disease (A4) study. Neurology 96, e1491–e1500 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Wilkins, C. H. et al. Racial and ethnic differences in amyloid PET positivity in individuals with mild cognitive impairment or dementia: a secondary analysis of the Imaging Dementia-Evidence for Amyloid Scanning (IDEAS) cohort study. JAMA Neurol. 79, 1139–1147 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Schindler, S. E. et al. Effect of race on prediction of brain amyloidosis by plasma Aβ42/Aβ40, phosphorylated tau, and neurofilament light. Neurology 99, e245–e257 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Windon, C. et al. IDEAS and New IDEAS: amyloid PET in diverse populations. Alzheimers Dement. 17, e051946 (2021).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Alzheimer’s Association, Chicago, IL, USA

    Maria C. Carrillo & Simin Mahinrad

Authors
  1. Maria C. Carrillo
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Simin Mahinrad
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maria C. Carrillo.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Carrillo, M.C., Mahinrad, S. Navigating complexities of racial disparities in Alzheimer disease biomarkers. Nat Rev Neurol 20, 205–206 (2024). https://doi.org/10.1038/s41582-024-00930-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41582-024-00930-6

  • Springer Nature Limited

Search

Navigation